Allium Medical Solutions - Termination of coverage
Edison Investment Research is terminating coverage on Allium Medical (ALMD). Please note you should no longer rely on any previous research or...
125 Views
Allium Medical Solutions - Continuing to execute on an ambitious plan
Following broad FDA approval for Gardia, Allium anticipates the publication of clinical study results in a leading cardiology journal. Allium...
168 Views
Allium Medical Solutions - Wirion approved by FDA; new stents in Europe
Allium has announced FDA approval of its subsidiary Gardia’s Wirion, which has become the only embolic protection system approved for all...
222 Views
Allium Medical Solutions - It is all about business execution
Gardia Medical’s Wirion device is on track for FDA submission, expected by end-2017; approval is possible in Q218. If approved, it would become the...
123 Views
Positive data, H117 results and forecasts update
Allium has announced that Gardia Medical’s Wirion device has met the primary endpoint of its clinical trial, an important milestone for strategic...
220 Views
No more insights